Since FA patients display a high risk of childhood acute myeloid leukemia (AML), we stably knocked down FANCA in the AML cell line THP‐1 to assess sensitivity to SIK2 inhibition in a relevant cancer type. The gene discussed is FANCA; the disease is cancer.